Most hospitals and health systems are the largest organizations in our communities, providing critical services necessary for each of our neighbors. We take care of our communities as best as possible – which means defending the support and resources we need.
A series of prices recently implemented could have important implications for health care. A large proportion of medical goods currently comes from international sources, including pharmaceutical products, medical devices and personal protective equipment, as well as other essential elements for low use, such as syringes, needles and blood pressure.
The prices on these articles could have an impact on patient care by ending the availability of vital drugs and essential health care devices. They could also increase costs for hospitals and increase the shortages and disruptions of the supply chain.
We have already seen the impact of the disturbances of the supply chain following Hurricane Helene. To continue to provide the care on which our communities count, hospitals and health systems need exemptions to guarantee access to essential imports.
The president and chief executive officer of the AHA, Rick Pollack, urged the administration To provide tariff exemptions for medicines and medical supplies.
AHA too Recently answered To a request for public comments on the national security survey of the Ministry of Commerce on pharmaceutical imports and imports of pharmaceutical ingredients, urging administration to maintain tariff exemptions to minimize patient disruptions to patient care.
We have seen the creativity, innovation and resilience of our hospitals to provide patient care during pandemic and other difficult circumstances. Health care managers can work to assess their supply chains to search for alternative sources, even if we plead on behalf of our patients.
There is also an important opportunity to make the supply chain more resilient. AHA A Worked with Congress To urge the examination of the legislation which would support efforts to map and proactively assess the chains of pharmaceutical supplies, medical devices and equipment.
I will speak with Brian Pomper, partner with Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice-president of the quality of quality and safety of AHA patients, for a next dialogue on prices. Join us to find out more about the potential impact on health care and how managers can prepare.
Help you help communities: AHA key resources